Editorial: Immunotherapy for NSCLC with oncogenic driver variants

Affiliations

• ¹ Thoracic Oncology Ward, Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
• ² Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ³ Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States.
• ⁴ Department of Respiratory Medicine, Daping Hospital, Army Medical University, Chongqing, China.
• ⁵ Department of Rheumatology and Immunology, State Key Laboratory of Biotherapy and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
• ⁶ Division of Pathogenesis of Virus Associated Tumors, German Cancer Research Centre Deutsches Krebsforschungszentrum(DKFZ), Heidelberg University, Heidelberg, Germany.